Cube Labs SpA
MIL:CUBE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its Industry Average (7.9), the stock would be worth €0.03 (99% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 557.6 | €2.42 |
0%
|
| Industry Average | 7.9 | €0.03 |
-99%
|
| Country Average | 7.6 | €0.03 |
-99%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| IT |
C
|
Cube Labs SpA
MIL:CUBE
|
46.1m EUR | 557.6 | -168.5 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
230B USD | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 3 417.4 | 4 020.7 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
97.4B ZAR | 14.2 | 10.4 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
35.5B CHF | 0 | 0 | |
| US |
I
|
Inspire Veterinary Partners Inc
NASDAQ:IVP
|
38.9B USD | -5 033.1 | -3 258.5 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
37.6B USD | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
29.4B EUR | 29.1 | 161 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
30.4B USD | -3 656.4 | -2 788.5 | |
| ZA |
F
|
Fortress Real Estate Investments Ltd
JSE:FFB
|
28.3B ZAR | 11.2 | 8.1 |
Market Distribution
| Min | 0.7 |
| 30th Percentile | 5.2 |
| Median | 7.6 |
| 70th Percentile | 10.8 |
| Max | 3 328.6 |
Other Multiples
Cube Labs SpA
Glance View
Cube Labs SpA provides healthcare technology services. The company is headquartered in Rome, Roma and currently employs 2 full-time employees. The company went IPO on 2023-03-21. The firm creates companies from R&D stage and provides entrepreneurial and operational support into healthcare management and technology solutions. The company also promotes and implements results of scientific research in the field of human health, biotechnology and nanotechnology. The firm operates globally.
